AU2123997A - Methods of inhibiting colon tumors - Google Patents

Methods of inhibiting colon tumors

Info

Publication number
AU2123997A
AU2123997A AU21239/97A AU2123997A AU2123997A AU 2123997 A AU2123997 A AU 2123997A AU 21239/97 A AU21239/97 A AU 21239/97A AU 2123997 A AU2123997 A AU 2123997A AU 2123997 A AU2123997 A AU 2123997A
Authority
AU
Australia
Prior art keywords
methods
colon tumors
inhibiting colon
inhibiting
tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU21239/97A
Other versions
AU707892B2 (en
Inventor
Maria L. Brandi
Francesco Tonelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2123997A publication Critical patent/AU2123997A/en
Application granted granted Critical
Publication of AU707892B2 publication Critical patent/AU707892B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
AU21239/97A 1996-01-29 1997-01-27 Methods of inhibiting colon tumors Ceased AU707892B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
US60/010772 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors
GB96/03150 1996-02-15
PCT/US1997/002286 WO1997026877A1 (en) 1996-01-29 1997-01-27 Methods of inhibiting colon tumors

Publications (2)

Publication Number Publication Date
AU2123997A true AU2123997A (en) 1997-08-20
AU707892B2 AU707892B2 (en) 1999-07-22

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21239/97A Ceased AU707892B2 (en) 1996-01-29 1997-01-27 Methods of inhibiting colon tumors

Country Status (19)

Country Link
EP (1) EP0921799A4 (en)
JP (1) JP2000503994A (en)
KR (1) KR19990082054A (en)
CN (1) CN1209745A (en)
AR (1) AR010978A1 (en)
AU (1) AU707892B2 (en)
BR (1) BR9700778A (en)
CO (1) CO4761062A1 (en)
CZ (1) CZ235498A3 (en)
EA (1) EA001104B1 (en)
ID (1) ID15917A (en)
IL (1) IL125521A (en)
MX (1) MX9806036A (en)
NO (1) NO983451L (en)
NZ (1) NZ331105A (en)
PL (1) PL328147A1 (en)
TW (1) TW446560B (en)
WO (1) WO1997026877A1 (en)
YU (1) YU2397A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
ATE220323T1 (en) * 1993-10-15 2002-07-15 Lilly Co Eli METHOD OF TREATING RESISTANT NEOPLASMS
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
CO4761062A1 (en) 1999-04-27
AU707892B2 (en) 1999-07-22
ID15917A (en) 1997-08-21
IL125521A0 (en) 1999-03-12
EA001104B1 (en) 2000-10-30
CN1209745A (en) 1999-03-03
JP2000503994A (en) 2000-04-04
YU2397A (en) 1999-11-22
TW446560B (en) 2001-07-21
EP0921799A1 (en) 1999-06-16
MX9806036A (en) 1998-11-29
NO983451D0 (en) 1998-07-27
EA199800677A1 (en) 1999-02-25
WO1997026877A1 (en) 1997-07-31
NO983451L (en) 1998-07-27
CZ235498A3 (en) 1999-02-17
EP0921799A4 (en) 2002-03-13
BR9700778A (en) 1998-10-06
IL125521A (en) 2001-11-25
KR19990082054A (en) 1999-11-15
AR010978A1 (en) 2000-08-02
PL328147A1 (en) 1999-01-18
NZ331105A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
AU1939200A (en) Electrochemical treatment of malignant tumors
AU4635597A (en) Gene synthesis method
AU3986597A (en) Automatic sequencer/genotyper having extended spectral response
AU6148898A (en) 2-substituted 7-haloindenes and methods for synthesizing
PL327998A1 (en) Novel derivatives of 19-nor-pregnene
AU3299195A (en) Inhibition of helicobacter
AU4296397A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU3769097A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU5372598A (en) Tfpx synthesis
AU5005697A (en) Methods of preventing breast cancer
AU2217797A (en) Synthesis of indolylmaleimides
AU1210797A (en) Cancerous metastasis inhibitor
AU6109096A (en) Methods of inhibiting melanoma
AU4157097A (en) Synthesis of bisindolylmalimides
AU1600597A (en) Stabilisation of polyolefin-recyclates
HU9702480D0 (en) New polymorphe modification of doxazosin-mesylate
AU1110799A (en) Method of inhibiting metastases of cancer cells
AU5126298A (en) Inhibition of crib-biting
AU1600297A (en) Aryl derivatives
AU3370095A (en) Methods of inhibiting endometrial cancer
AU2123997A (en) Methods of inhibiting colon tumors
AU5028696A (en) Methods of inhibiting ovarian cancer
AU5825896A (en) Well inhibition
ZA97621B (en) Methods of inhibiting colon tumors
GB9603150D0 (en) Methods of inhibiting colon tumors

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired